EFM
CERE

E Fund Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

E Fund Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
2024
Q2 		$455K Buy
2024
Q1 		$444K Buy
2023
Q4 		$322K Sell
2023
Q3 		$223K Buy
2023
Q2 		$302K Sell
2023
Q1 		$291K Sell
2022
Q4 		$395K Buy
2022
Q3 		$294K Buy
2022
Q2 		$224K Buy